➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Johnson and Johnson
Colorcon
Medtronic

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 9,808,540

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 9,808,540
Title:Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
Abstract: The present invention relates to a contrast agent for nuclear magnetic resonance imaging, and more particularly, to a contrast agent for nuclear magnetic resonance imaging containing melanin nanoparticles having a uniform shape and size, thereby providing good dispersibility in water, no cell toxicity, and a long retention time in vivo.
Inventor(s): Lee; Jin Kyu (Seoul, KR), Ju; Kuk Youn (Seoul, KR), Lee; Jung Hee (Seoul, KR)
Assignee: Melanis Co., Ltd. (Seoul, KR)
Application Number:14/391,217
Patent Claims:see list of patent claims

Details for Patent 9,808,540

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 2019-02-28 ⤷  Free Forever Trial Melanis Co., Ltd. (Seoul, KR) 2032-04-09 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 2004-06-18 ⤷  Free Forever Trial Melanis Co., Ltd. (Seoul, KR) 2032-04-09 RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 1998-09-25 ⤷  Free Forever Trial Melanis Co., Ltd. (Seoul, KR) 2032-04-09 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.